v3.25.1
CONTRACT WITH CUSTOMER (Details Narrative) - USD ($)
3 Months Ended
Aug. 31, 2023
Mar. 31, 2025
Mar. 31, 2024
Sep. 24, 2024
Disaggregation of Revenue [Line Items]        
Proceeds from option and license agreement $ 300,000      
Proceeds from cell line customization activities $ 400,000      
Revenue recognized   $ 0 $ 100,000  
Option fee obligation payment percentage   20.00%    
License fees   $ 0 100,000  
Transferred over Time [Member]        
Disaggregation of Revenue [Line Items]        
Revenue recognized     $ 400,000  
Lineage Assignment Agreement [Member]        
Disaggregation of Revenue [Line Items]        
Payments, percentage       30.00%
Lineage Assignment Agreement [Member] | Factor Bioscience Limited [Member]        
Disaggregation of Revenue [Line Items]        
Payments, percentage       20.00%